Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia

Haematologica

Volumn 99, Issue 1, 2014, Pages 1-4

  Cox, Sharon E ^a,b   Soka, Deogratias ^b   Kirkham, Fenella J ^d   Newton, Charles R J ^b,c   Prentice, Andrew M ^a   Makani, Julie ^b,f   Younoszai, Adel K ^e  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anemia; Echocardiography; Hemolysis; Oxygen saturation; Sickle cell

Indexed keywords

ANEMIA; ECHOCARDIOGRAPHY; HEMOLYSIS; OXYGEN SATURATION; SICKLE CELL;

ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; HOSPITALIZATION; HUMANS; TANZANIA; TRICUSPID VALVE INSUFFICIENCY;

EID: 84892589760     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.089235     Document Type: Letter

References (23)

1. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134(1):109-115.
2. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886-895.
3. Sutton LL, Castro O, Cross DJ, Spencer JE, Lewis JF. Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994;74(6):626-628.
4. Lorch D, Spevack D, Little J. An elevated estimated pulmonary arterial systolic pressure, whenever measured, is associated with excess mortality in adults with sickle cell disease. Acta Haematol. 2011;125(4):225-229.
5. Minniti CP, Sable C, Campbell A, Rana S, Ensing G, Dham N, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica. 2009;94(3):340-347.
6. Liem RI, Young LT, Thompson AA. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica. 2007;92(11):1549-1552.
7. Colombatti R, Maschietto N, Varotto E, Grison A, Grazzina N, Meneghello L, et al. Pulmonary hypertension in sickle cell disease children under 10 years of age. Br J Haematol. 2010;150(5):601-609.
8. Johnson MC, Kirkham FJ, Redline S, Rosen CL, Yan Y, Roberts I, et al. Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood. 2010;116(1):16-21.
9. Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics. 2008;121(4):777-782.
10. Makani JK, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, et al. Malaria in patients with sickle cell anemia: burden, risk factors and outcome at outpatient clinic and during hospitalization. Blood. 2010;115(2):215-220.
11. Cnaan A, Ryan L. Survival analysis in natural history studies of disease. Stat Med. 1989;8(10):1255-1268.
12. Chaudry RA, Cikes M, Karu T, Hutchinson C, Ball S, Sutherland G, et al. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance. Arch Dis Child. 2011;96(2):131-136.
13. Ballas SK. Lactate dehydrogenase and hemolysis in sickle cell disease. Blood. 2013;121(1):243-244.
14. Dham N, Ensing G, Minniti C, Campbell A, Arteta M, Rana S, et al. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol. 2009;104(5):713-720.
15. Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, et al. Relationship of erythropoietin, fetal hemoglobin, and hydrox-yurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood. 2009;114(21):4639-4644.
16. Aliyu ZY, Gordeuk V, Sachdev V, Babadoko A, Mamman AI, Akpanpe P, et al. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol. 2008;83(6):485-490.
17. Hebbel RP. Reconstructing sickle cell disease: a data-based analysis of the hyperhemolysis paradigm for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol. 2011;86(2):123-154.
18. Campbell A, Minniti CP, Nouraie M, Arteta M, Rana S, Onyekwere O, et al. Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients. Br J Haematol. 2009;147(3):352-359.
19. Niu X, Nouraie M, Campbell A, Rana S, Minniti CP, Sable C, et al. Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS ONE. 2009;4(11):e7956.
20. Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA. 2006;296(3):310-318.
21. Machado RF, Hildesheim M, Mendelsohn L, Remaley AT, Kato GJ, Gladwin MT. NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease. Br J Haematol. 2011;154(4):512-520.
22. Oguanobi NI, Ejim EC, Anisiuba BC, Onwubere BJ, Ike SO, Ibegbulam OG, et al. Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension. ISRN Hematol. 2012;2012:768718.
23. Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr. 2012;160(2):286-290.